Robin K. Avery

17.8k citations
236 papers · 11.6k · 5 hit papers · h-index 56

Impact in

Papers in

    • Cytomegalovirus and herpesvirus research 73
    • Herpesvirus Infections and Treatments 21
    • Antifungal resistance and susceptibility 23
    • COVID-19 Clinical Research Studies 22
    • SARS-CoV-2 and COVID-19 Research 21

Robin K. Avery

224 papers receiving 11.2k citations

Robin K. Avery's Hit Papers

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients 2021 · 600 citations
6000+4+8Years since publication2505007501000

Peers

Robin K. Avery
Comparison fields: 5 of 128
  • Transplantation 1.0k
  • Infectious Diseases 4.2k
  • Epidemiology 5.7k
  • Microbiology 66
  • Hepatology 578
Replace José María Aguado with:
José María Aguado Spain
Lindsey R. Baden United States
Raymund R. Razonable United States
Atul Humar Canada
Per Ljungman Sweden
Asunción Moreno Spain
Emily A. Blumberg United States
Ajit P. Limaye United States
Michael G. Ison United States
Angela M. Caliendo United States
Robin K. Avery relative to José María Aguado Spain José María Aguado's profile →
Citations per field
00.5×1.5×2.1×
José María Aguado · 1×
Citations per year

Countries citing papers authored by Robin K. Avery

Since Specialization
Citations

This map shows the geographic impact of Robin K. Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin K. Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin K. Avery more than expected).

Fields of papers citing papers by Robin K. Avery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin K. Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin K. Avery. The network helps show where Robin K. Avery may publish in the future.

Co-authors

The 25 scholars most cited alongside Robin K. Avery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin K. Avery Line = papers co-authored together Robin K. Avery links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 236 papers — load more, or switch the sort, to bring in the rest.

#Work
1
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Hit paper breakdown →
20131161
2
Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Hit paper breakdown →
2014727
3
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Hit paper breakdown →
2021600
4
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
Hit paper breakdown →
2021344
5 2002298
6 2003272
7 2009240
8 2003195
9 2010194
10 2020193
11
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
Hit paper breakdown →
2021185
12 2018173
13 2018171
14 2011169
15 1998162
16 2009158
17 1999155
18 2011140
19 2009134
20 2016130

About Robin K. Avery

Robin K. Avery is a scholar working on Epidemiology, Infectious Diseases, Oncology, Surgery and Transplantation, having authored 236 papers that have together received 11.6k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (73 papers), Transplantation: Methods and Outcomes (27 papers), Antifungal resistance and susceptibility (23 papers), Polyomavirus and related diseases (22 papers), COVID-19 Clinical Research Studies (22 papers), Herpesvirus Infections and Treatments (21 papers), SARS-CoV-2 and COVID-19 Research (21 papers) and Renal Transplantation Outcomes and Treatments (17 papers). The work is most often cited by research in Transplantation (1.0k citations), Infectious Diseases (4.2k citations), Epidemiology (5.7k citations), Microbiology (66 citations) and Hepatology (578 citations). Robin K. Avery has collaborated with scholars based in United States, Canada and Thailand. Frequent co-authors include Per Ljungman, Allan B. Massie, William A. Werbel, Dorry L. Segev, Jacqueline Garonzik‐Wang, Brian J. Boyarsky, Harry Keyserling, Insoo Kang, Myron J. Levin and Lorry G. Rubin. Their work appears in journals such as American Journal of Transplantation, Transplantation, Clinical Infectious Diseases, The Journal of Heart and Lung Transplantation and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact